Veno-venous Extracorporeal Membrane Oxygenation Support in COVID-19 Respiratory Distress Syndrome: Initial Experience.

Antonino LoforteErika Dal CheccoGregorio GliozziMaria BenedettoGiulio Giovanni CavalliCarlo MarianiGiulia PicconeMarta AgulliDavide PaciniMassimo Baiocchi

Published in: ASAIO journal (American Society for Artificial Internal Organs : 1992) (2020)

SARS-CoV-2 may cause severe respiratory failure due to massive alveolar damage. Currently, no adequate curative therapy for Coronavirus Disease 2019 (COVID-19) disease exists. By considering overall impact of COVID-19 pandemic outbreak, an increased need of extracorporeal membrane oxygenation (ECMO) support becomes evident. We report on our preliminary institutional experience with COVID-19 patients receiving venovenous ECMO support.

Keyphrases

extracorporeal membrane oxygenation
coronavirus disease
sars cov
respiratory failure
acute respiratory distress syndrome
respiratory syndrome coronavirus
mechanical ventilation
oxidative stress
early onset
case report
rectal cancer
prognostic factors